Initiation of protein synthesis by a labeled derivative of the Lactobacillus casei DN-114 001 strain during transit from the stomach to the cecum in mice harboring human microbiota

Applied and Environmental Microbiology

Volumn 70, Issue 12, 2004, Pages 6992-6997

  Oozeer, R ^a   Mater, D D G ^a   Goupil Feuillerat, N ^b   Corthier, G ^a  

^a CEMAGREF   (France)

^b DANONE RESEARCH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; BIOSYNTHESIS; CELL CULTURE; DAIRY PRODUCTS; DERIVATIVES; FERMENTATION; GENES; METABOLISM; PHYSIOLOGY;

FERMENTED MILK; LUCIFERASE; PHYSIOLOGICAL ADAPTATION; PROTEIN SYNTHESIS;

PROTEINS;

LUCIFERASE;

DIGESTIVE SYSTEM; MICROBIOLOGY; PROBIOTICS;

ANIMAL MODEL; ARTICLE; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIAL SURVIVAL; CECUM; DIGESTIVE SYSTEM; DUODENUM; GENE CONTROL; HOST PATHOGEN INTERACTION; ILEUM; INTESTINE TRANSIT TIME; JEJUNUM; LACTOBACILLUS CASEI; MILK; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; STOMACH; TRANSCRIPTION INITIATION;

ANIMALS; CECUM; COLONY COUNT, MICROBIAL; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLUS CASEI; LUCIFERASES; MICE; MICE, INBRED C3H; PROBIOTICS; PROTEINS; STOMACH;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS CASEI; MICROBIOTA; POSIBACTERIA;

EID: 10444245952     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.70.12.6992-6997.2004     Document Type: Article

References (26)

1. Alpert, C.-A., and U. Siebers. 1997. The lac operon of Lactobacillus casei contains lacT, a gene coding for a protein of the Bg1G family of transcriptional antiterminators. J. Bacteriol. 179:1555-1562.
2. Bengmark, S. 1998. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 42:2-7.
3. Berrada, N., J. F. Lemeland, G. Laroche, P. Thouvenot, and M. Piaia. 1991. Bifidobacterium from fermented milks: survival during gastric transit. J. Dairy Sci. 74:409-413.
4. Borruel, N., M. Carol, F. Casellas, M. Antolin, F. de Lara, E. Espin, J. Naval, F. Guarner, and J. R. Malagelada. 2002. Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be down regulated ex vivo by probiotic bacteria. Gut 51:659-664.
5. Bunte, C., C. Hertei, and W. P. Hammes. 2000. Monitoring and survival of Lactobacillus paracasei LTH 2579 in food and the human intestinal tract. Syst. Appl. Microbiol. 23:260-266.
6. Contrepois, M., and P. Gouet. 1969. Utilisation d'une technique microbiologique pour la mesure de la vitesse des microparticules dans le tractus digestif des ruminants. C. R. Acad. Sci. (Paris) 268:1757-1759.
7. De Man, J. C., M. Rogosa, and M. E. Sharpe. 1960. A medium for the cultivation of Lactobacilli. J. Appl. Bacteriol. 23:130-135.
8. Drouault, S., G. Corthier, S. D. Ehrlich, and P. Renault. 1999. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ. Microbiol. 65:4881-4886.
9. Ducluzeau, R., M. Bellier., and P. Raibaud. 1970. Transit through the digestive tract of the inocula of several bacterial strains introduced "per Os" into axenic and "Holoxenic" mice. The antagonistic effect of the microflora of the gastrointestinal tract. Zentbl. Bakteriol. 213:533-548.
10. Fuller, R. 1991. Probiotics in human medicine. Gut 32:439-442.
11. Ganz, T. 2000. Paneth cells - guardians of the gut cell hatchery. Nat. Immunol. 1:99-100.
12. Guarner, F., and G. J. Schaafsma. 1998. Probiotics. Int. J. Food. Microbiol. 39:237-238.
13. Kailasapathy, K., and J. Chin. 2000. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol. Cell Biol. 78:80-88.
14. Klijn, N., A. H. Weerkamp, and W. M. de Vos. 1995. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl. Environ. Microbiol. 61:2771-2774.
15. Marteau, P., and J. C. Rambaud. 1993. Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol. Rev. 12:207-220.
16. Nouaille, S., L. A. Ribeiro, A. Miyoshi, D. Pontes, Y. Le Loir, S. C. Oliveira, P. Langella, and V. Azevedo. 2003. Heterologous protein production and delivery systems for Lactococcus lactis. Genet. Mol. Res. 2:102-111.
17. Oozeer, R., N. Goupil-Feuillerat, C. A. Alpert, M. van de Guchte, J. Anba, J. Mengaud, and G. Corthier. 2002. Lactobacillus casei is able to survive and initiate protein synthesis during its transit in the digestive tract of human flora-associated mice. Appl. Environ. Microbiol. 68:3570-3574.
18. Paubert-Braquet, M., G. X.-H. C. Gaudichon, N. Hedef, A. Serikoff, C. Bouley, B. Bonavida, and P. Braquet. 1995. Enhancement of host resistance against Salmonella typhimurium in mice fed a diet supplemented with yogurt or milks fermented with various Lactobacillus casei strains. Int. J. Immunother. 11:153-161.
19. Pedone, C. A., C. C. Arnaud, E. R. Postaire, C. F. Bouley, and P. Reinert. 2000. Multicentric study of the effect of milk fermented by Lactobacillus casei on the incidence of diarrhoea. Int. J. Clin. Pract. 54:568-571.
20. Pedone, C. A., A. O. Bernabeu, E. R. Postaire, C. F. Bouley, and P. Reinert. 1999. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN-114 001) on acute diarrhoea in children attending day care centres. Int. J. Clin. Pract. 53:179-184.
21. Perdigon, G., E. Vintini, S. Alvarez, M. Medina, and M. Medici. 1999. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J. Dairy Sci. 82:1108-1114.
22. Rachmilewitz, D., K. Katakura, F. Karmeli, T. Hayashi, C. Reinus, B. Rudensky, S. Akira, K. Takeda, J. Lee, K. Takabayashi, and E. Raz. 2004. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126:520-528.
23. Reid, G., F. Guarner, G. Gibson, T. Tompkins, H. Gill, I. Rowland, B. Rastall, B. Pot, and M. E. Sanders. 2004. Discussion on Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 127:366-367.
24. Steidler, L. 2001. Lactococcus lactis, a tool for the delivery of therapeutic proteins treatment of IBD. Sci. World J. 1:216-217.
25. Vesa, T., P. Pochart, and P. Marteau. 2000. Pharmacokinetics of Lactobacillus plantarum NCIMB 8826, Lactobacillus fermentum KLD, and Lactococcus lactis MG 1363 in the human gastrointestinal tract. Aliment. Pharmacol. Ther. 14:823-828.
26. Yuki, N., K. Watanabe, A. Mike, Y. Tagami, R. Tanaka, M. Ohwaki, and M. Morotomi. 1999. Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies. Int. J. Food Microbiol. 48:51-57.